Clinical Trials Logo

Drug Overdose clinical trials

View clinical trials related to Drug Overdose.

Filter by:

NCT ID: NCT03821649 Completed - Overdose Clinical Trials

SOONER Feasibility Study Protocol

SOONER
Start date: January 23, 2019
Phase: N/A
Study type: Interventional

Opioid Overdose Education and Naloxone Distribution programs (OEND) involve training and equipping people who are likely to be bystanders to opioid overdose to recognize and respond to opioid-related emergencies by activating emergency services, delivering basic life support and administering naloxone. The goal of the Surviving Opioid Overdose with Naloxone Education and Resuscitation (SOONER) trial is to identify if point-of-care OEND increases rates of satisfactory bystander resuscitative performance to simulated opioid overdose in comparison with the existing standard of care. Recruitment and retention of participants at risk of overdose, and the acceptability of the simulated overdose outcome may challenge the feasibility of the SOONER trial. The primary objective is to identify if an integrated participant recruitment and retention strategy can recruit approximately 28 eligible participants within 4 weeks and maintain less than 50% attrition in the context of a randomized trial on point-of-care OEND and simulated overdose resuscitation performance in family practice, emergency department, and addictions settings in Toronto, Ontario. After the initial 28 participants, we are continuing to recruit up to 50 more participants in a bridging phase that leads into the full trial.

NCT ID: NCT03798470 Completed - Opioid-use Disorder Clinical Trials

FAVOR Opioid Recovery Coaching Evaluation

FORCE
Start date: January 1, 2018
Phase: N/A
Study type: Interventional

The Emergency Department (ED) is an ideal location to identify patients in need of treatment for opioid addiction. A local non-profit community-based addiction recovery program, Faces and Voices of Recovery (FAVOR) utilizes a peer recovery coaching model applied to substance use disorders by identifying, training, credentialing and supervising individuals who have been in recovery for at least 2 years. These peer recovery coaches become the primary workforce in this community-based model. FAVOR provides no-cost comprehensive services for addiction recovery. The investigators hypothesized that having FAVOR Recovery Coaches (FRC) evaluate patients during an ED visit for opioid overdose would result in a high degree of engagement from the patients and serve as an opportunity to begin treatment for addiction.

NCT ID: NCT03570099 Active, not recruiting - Opioid Abuse Clinical Trials

Naloxone Treatment in Skåne County - Effect on Drug-related Mortality and Overdose-related Complications

Start date: June 11, 2018
Phase:
Study type: Observational [Patient Registry]

Death in overdose is the single most common cause of death in people using heroin. In Sweden, the number of drug-related overdose deaths has increased gradually since the early 1990s. The purpose of the study is to investigate the effects of a Naloxone distribution program in Skåne County. The primary issue is whether the project had an effect on overdose mortality and overdose related injuries.

NCT ID: NCT03569592 Completed - Clinical trials for Drug Overdose Accidental

Addressing Overdose Risk Among Recently Incarcerated People Living With HIV/AIDS

Start date: January 22, 2018
Phase: N/A
Study type: Interventional

The overall objective of this study is to evaluate an educational overdose prevention intervention's effectiveness among incarcerated people living with HIV/AIDS, specifically within the context of other outcomes related to health and experiences after incarceration. Results will be used to develop tailored interventions to reduce overdose deaths among high-risk correctional populations. The research has the following aims: - Aim 1: Evaluate a pilot program to provide HIV+ inmates with 1:1 overdose prevention training while incarcerated; - Aim 2: Identify the criminal justice, health, and HIV-related factors associated with overdose risk; and - Aim 3: Describe the overdose risk experiences of HIV+ former inmates who use opioids after release.

NCT ID: NCT03533179 Completed - Drug Overdose Clinical Trials

Glucagon's Cardiovascular Effects With and Without Beta-blocker-induced Cardioinhibition

GLUCAGON
Start date: June 1, 2018
Phase: Phase 4
Study type: Interventional

This trial investigates effects of a glucagon bolus injection on heart rate, blood pressure and cardiac output during beta-blocker-induced cardiodepression. Furthermore, the effects of two different doses of intravenous glucagon on hemodynamic parameters are explored.

NCT ID: NCT03518021 Completed - Drug Abuse Clinical Trials

Naloxone Nasal Spray Compared With Naloxone Injection for Opioid Overdoses Outside the Hospital

NINA-1
Start date: May 15, 2018
Phase: Phase 3
Study type: Interventional

This trial will compare the clinical response to intramuscular and intranasal naloxone in pre-hospital opioid overdoses. Objective of the study is to measure and evaluate clinical response (return of spontaneous respiration within 10 minutes of naloxone administration) to a new nasal naloxone formulation in real opioid overdoses in the pre-hospital environment. The aim is to demonstrate that intranasal administration of naloxone is not clinically inferior to intramuscular administration, which is now standard treatment of care.

NCT ID: NCT03489161 Completed - Opioid-use Disorder Clinical Trials

Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal

Start date: August 1, 2018
Phase: Early Phase 1
Study type: Interventional

The investigators are trying to determine whether they can effectively treat patients suffering from acute opioid withdrawal in the Emergency Department at Virginia Commonwealth University Health System (VCUHS) and subsequently transfer them to an outpatient addiction clinic within the existing infrastructure. This will be a descriptive investigation of the process to reveal areas of success and opportunities for improvement in order to determine feasibility of the study procedures in preparation for a larger clinical investigation.

NCT ID: NCT03482232 Completed - Adverse Event Clinical Trials

Consequences of Doing What Should Not be Done in Primary Care

SOBRINA
Start date: October 14, 2018
Phase:
Study type: Observational

Retrospective observational study in a random selection of 5% of digital records active between 2014 and 2017 to quantify the frequency of Do not do primary care recommendations, calculating the over-cost related to them and study reviewing a random selection of cases previously identified to determine whether patient suffered adverse events and their over-cost.

NCT ID: NCT03402672 Completed - Clinical trials for Substance Use Disorders

AWAITS: A Web-based E-health Application for Active Illicit Opioid Users

AWAITS
Start date: November 8, 2017
Phase: N/A
Study type: Interventional

The purpose of this research study is to: 1. assess how participants like the AWAITS e-health application as measured by their feedback on the intervention 2. test the impact of AWAITS on knowledge about opioid overdose and risk-reduction strategies. 3. assess the proportion of participants who accept a list of local treatment providers 4. test the impact of AWAITS on interest in being tested for HCV/HIV.

NCT ID: NCT03373825 Completed - Clinical trials for Accidental Overdose of Opiate

Rapid Self-Testing to Prevent Fentanyl Overdose Among Young People Who Use Drugs

RAPiDS2
Start date: May 15, 2017
Phase: N/A
Study type: Interventional

The research team will enroll 100 young adults who use cocaine, heroin, inject drugs, or purchase prescription medications on the illicit market in a pilot study to be known as the Rhode Island Young Adult Prescription and Illicit Drug Study (RAPIDS). Participants will be trained to use a take-home home rapid drug test to test for the presence or absence of fentanyl in their drug supply. Half of the enrolled participants will be asked to test their urine for presence or absence of fentanyl, and the other half will be asked to test their drug residue for presence or absence of fentanyl. All participants will receive up to 15 take-home rapid drug tests for fentanyl. A follow-up survey will examine and compare utilization of the tests between the two groups. The study will be guided by the information-motivation-behavioral skills (IMB) model of engagement in health behaviors. The IMB model hypothesizes that if a person possesses the information, motivation, and behavioral skills to act, there is an increased likelihood that she/he will fulfill and maintain the desired behaviors (behaviors that will reduce accidental overdose).